K

Kodiak Sciences
D

KOD

3.43500
USD
-0.11
(-3.10%)
مغلق
حجم التداول
7,500
الربح لكل سهم
-4
العائد الربحي
-
P/E
-1
حجم السوق
181,242,763
الأخبار المقالات

العنوان: Kodiak Sciences

القطاع: Healthcare
الصناعة: Biotechnology
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.